Dostarlimab-gxly, GlaxoSmithKline, Jemperli
Dostarlimab-gxly tare da chemotherapy an yarda da FDA don ciwon daji na endometrial
Agusta 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline), wanda dostarlimab-gxly ya biyo baya a matsayin wakili ɗaya, Cibiyar Abinci da Magunguna ta amince da ita don maganin ciwon daji na farko ko na gaba (EC..
dMMR, Dostarlimab-gxly, GlaxoSmithKline, Jemperli
Dostarlimab-gxly ta amince da FDA don ciwon daji na endometrial dMMR
Feb 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) an bai wa FDA izinin kula da manya marasa lafiya da rashin daidaituwa na gyara (dMMR) maimaituwa ko ci gaba da ciwon daji na endometrial wanda ya ci gaba a lokacin ko bayan kafin ..
dostarlimab, Gina Kolata, GlaxoSmithKline, Luis A. Diaz Jr, NEJM
Duk mahalarta a cikin ƙaramin gwajin cutar kansa sun sami cikakkiyar gafara
Yuni 2022: Wani ɗan ƙaramin bincike na masu ciwon sankara na dubura ya ba da sakamako na ban mamaki: kashi 100 na mutane suna cikin gafara. An buga sakamakon a cikin Jaridar New England Journal of Medicine a wannan makon. An ba da kuɗin gwajin gwajin ..